29.72 0.86(2.98%)09/13/2024
Immunovant Inc (IMVT)
Immunovant Inc (IMVT)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday? | 09/09 12:54 | benzinga.com |
| IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab | 09/09 09:35 | zacks.com |
| Top 2 Health Care Stocks That May Collapse This Quarter | 09/09 09:12 | benzinga.com |
| Roivant Provides Update on Graves' Disease Development Program | 09/09 07:00 | globenewswire.com |
| Immunovant Provides Update on Graves' Disease Development Program | 09/09 03:55 | globenewswire.com |
| Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report? | 09/05 12:36 | zacks.com |
| Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging | 08/06 08:25 | seekingalpha.com |
| Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus | 05/30 12:31 | zacks.com |
| Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024 | 05/29 16:01 | globenewswire.com |